Last reviewed · How we verify

NCT06707701

Correlation Among Various OLGA and OLGIM Stages, Digestive Symptom Scores, and Acupuncture Treatment in Patients with Chronic Atrophic Gastritis

Not yet recruiting Last updated 2 December 2024
What this trial tests

trial testing acupuncture in Chronic Atrophic Gastritis (CAG) in 400 participants. Not yet recruiting.

Timeline
30 December 2024
Primary endpoint
30 December 2025
30 December 2025

Quick facts

Lead sponsorYi Liang
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment400
Start date30 December 2024
Primary completion30 December 2025
Estimated completion30 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yi Liang — full company profile →

Who can join

Adults 18 to 75, any sex, with Chronic Atrophic Gastritis (CAG). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief Summary Template for the Study: The goal of this observational study is to examine the relationship between digestive symptom scores, serum pepsinogen indices, and histopathological OLGA and OLGIM systematic staging of the gastric mucosa in patients with chronic atrophic gastritis(CAG), aiming to determine the degree of correlation between clinical manifestations, non-invasive laboratory tests, and the gold standard of diagnostic histopathology.To evaluate the comprehensive therapy, readiness and acceptance of acupuncture, utilization rates of various acupuncture therapies, self-assessed efficacy of acupuncture, and endoscopic histopathological alterations in patients with CAG.According to the aforementioned study, it is anticipated to enhance the optimization of acupuncture clinical research protocols for chronic atrophic gastritis, improve treatment efficacy, and offer more effective and rational therapy alternatives for patients.The main question it aims to answer is: To determine if the outcomes of combined serologic testing of symptoms in patients with CAG can serve as a method for monitoring disease development and if long-term follow-up can be supported? A group of participants with recorded GI symptom scores and blood pepsinogen levels will respond to online survey questions regarding the severity of their chronic atrophic gastritis progression over the course of 1 year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of acupuncture

Trials testing the same drug.

Other recruiting trials for Chronic Atrophic Gastritis (CAG)

Currently open trials in the same condition.

Other Yi Liang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06707701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing